NIH-funded research R01 grant

Understanding the genetics behind age-related hearing loss

Official title: Molecular genetics of human age-related hearing loss

Funded at Stanford University · NIH-11079514 · Data updated 2026-11-12

This study is looking at how certain genes, especially one called LOXHD1, might affect hearing loss as we get older, and it aims to find ways to help delay or prevent this common issue.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startApril 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$618,184
NIH project number5R01AG081608-03
Project IDNIH-11079514 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over the age of 21 who are experiencing age-related hearing loss or are at risk for developing it.

Less likely to help

Patients with hearing loss due to non-age-related factors, such as noise exposure or genetic disorders unrelated to aging, may not benefit from this research.

What this research studies

This research investigates the molecular pathways that contribute to age-related hearing loss (ARHL) in humans. By analyzing genetic variants associated with ARHL, the study aims to identify functional networks that could help delay or prevent this condition. The researchers will focus on a specific gene, LOXHD1, which plays a crucial role in the hearing process, and will use mouse models to explore how genetic variations affect hearing. This approach could lead to new insights into the mechanisms of hearing loss as we age.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating age-related hearing loss, improving communication and quality of life for older adults.

How similar studies have gone: Previous research has successfully identified genetic factors associated with hearing loss, suggesting that this approach has the potential for meaningful advancements in understanding ARHL.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Grillet, Nicolas — Stanford University
  • Study coordinator: Grillet, Nicolas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.